Nearly a third of publicly-traded biotechs are trading for less than the cash on their balance sheets, says RTW's Wong
2022|01:59Dr. Rod Wong, managing partner and CIO of RTW Investments, which specializes in biotech, joins the 'Halftime Report' to discuss where he sees opportunity in the biotech space.